The global tardive dyskinesia therapeutics market is poised for steady growth over the coming years, reflecting an increasing focus on patient-centric care and the rising prevalence of antipsychotic-induced movement disorders. Tardive dyskinesia (TD), a neurological disorder characterized by involuntary, repetitive body movements, has become a growing concern among patients undergoing long-term...
Deutsch
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek